Form 4: Apyx Medical Corp CFO Matthew C. Hill Reports Stock Option Grant

Matthew C. Hill, CFO of Apyx Medical Corp, reports the acquisition of stock options.

Summary

• Matthew C. Hill, the Chief Financial Officer of Apyx Medical Corporation, filed a Form 4 with the SEC.
• The report details a transaction that occurred on May 15, 2025, where Hill was granted a stock option to buy 100,000 shares of Apyx Medical Corp common stock at an exercise price of $1.48.
• The options vest ratably over 36 months and will be fully vested and exercisable on the third anniversary of the grant date, May 15, 2028.
• Following the transaction, Hill directly owns derivative securities consisting of options for 100,000 shares.

Sentiment

Score: 7

Explanation: The document reports a standard executive compensation practice (stock option grant), which is generally viewed neutrally to positively as it aligns management incentives with shareholder value.

Positives

• The grant of stock options to the CFO aligns his interests with those of the shareholders, incentivizing him to improve the company's performance.

Industry Context

Stock option grants are a common form of executive compensation in the medical device industry, aligning management's interests with those of shareholders.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive sign, aligning the CFO's interests with the company's long-term success.

Key Dates

Keywords

Stock Option, Form 4, Apyx Medical Corp, Matthew C. Hill, CFO, Beneficial Ownership